Novonesis (Novozymes A/S)
Transactions under Novonesis’ share buyback program
Transactions under Novonesis’ share buyback program
As of June 20th, 2025, Novonesis has purchased an accumulated 1,660,344 shares with a transaction value of DKK 713,0 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025. Under the program, Novonesis will buy back B shares worth up to EUR 100 million (DKK 746 million) in total during the remainder of 2025.
Please read the full announcement in PDF
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Digitalist Group Oyj15.12.2025 19:08:39 CET | Press release
Digitalist Group Oyj - Managers' Transactions
Solvay S.A.15.12.2025 17:45:00 CET | Press release
Participation notification by UBS Group AG
Ipsen Pharma15.12.2025 17:30:00 CET | Press release
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
Aspo Plc15.12.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 15.12.2025
Ress Life Investments A/S15.12.2025 17:10:00 CET | Press release
Ress Life Investments A/S publishes Net Asset Value (NAV)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom